Duration of Breast Drain in-situ and the Incidence of Seroma - Does a drain play a role
Association of Breast Surgery ePoster Library. Kwek A. 05/15/17; 166273; P066
Adriel Ju Wen Kwek
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Introduction: The use of drains in breast cancer surgery remains a topic of debate. This audit aimed to review the role of maximum 1-day drainage versus maximum 3-day drainage or 5-day protocol in patients undergoing breast cancer surgery.
Method: A prospective audit of all patients undergoing breast cancer surgery with mastectomy and/or axillary clearance was performed over 3 time periods when the local drain removal policy changed from <50ml daily or maximum 5 days (Cycle 1) to <50ml daily or maximum 3-day (Cycle 2) to <50ml daily or maximum 1-day (Cycle 3). Mann-Whitney and Kruskal Wallis tests were performed using SPSS v22.
Results: A total of 183 patients were reviewed (61 patients per cycle). There was no significant difference between the baseline patient, tumour and treatment factors between all 3 groups. There were no significant differences in seroma incidence (5-day vs 1-day 46% vs 58%, p=NS; 3-day vs 1-day 52% vs 58%, p=NS, number of aspiration (mean 5-day vs 1-day 3 vs 2 p=NS; 3-day vs 1-day 2 vs 2 p=NS) or volume of aspiration (5-day vs 1-day: 716 vs 467mls p=NS; 3-day vs 1-day: 588 vs 467mls p=NS). Factors influencing seroma rates are detailed in Table 1.
Conclusion: Removal of drains after one day does not significantly affect seroma incidence, nor number and volume of seroma aspiration. Seroma rates are affected by poor prognostic factors and extent of axillary disease.
Method: A prospective audit of all patients undergoing breast cancer surgery with mastectomy and/or axillary clearance was performed over 3 time periods when the local drain removal policy changed from <50ml daily or maximum 5 days (Cycle 1) to <50ml daily or maximum 3-day (Cycle 2) to <50ml daily or maximum 1-day (Cycle 3). Mann-Whitney and Kruskal Wallis tests were performed using SPSS v22.
Results: A total of 183 patients were reviewed (61 patients per cycle). There was no significant difference between the baseline patient, tumour and treatment factors between all 3 groups. There were no significant differences in seroma incidence (5-day vs 1-day 46% vs 58%, p=NS; 3-day vs 1-day 52% vs 58%, p=NS, number of aspiration (mean 5-day vs 1-day 3 vs 2 p=NS; 3-day vs 1-day 2 vs 2 p=NS) or volume of aspiration (5-day vs 1-day: 716 vs 467mls p=NS; 3-day vs 1-day: 588 vs 467mls p=NS). Factors influencing seroma rates are detailed in Table 1.
Conclusion: Removal of drains after one day does not significantly affect seroma incidence, nor number and volume of seroma aspiration. Seroma rates are affected by poor prognostic factors and extent of axillary disease.
Introduction: The use of drains in breast cancer surgery remains a topic of debate. This audit aimed to review the role of maximum 1-day drainage versus maximum 3-day drainage or 5-day protocol in patients undergoing breast cancer surgery.
Method: A prospective audit of all patients undergoing breast cancer surgery with mastectomy and/or axillary clearance was performed over 3 time periods when the local drain removal policy changed from <50ml daily or maximum 5 days (Cycle 1) to <50ml daily or maximum 3-day (Cycle 2) to <50ml daily or maximum 1-day (Cycle 3). Mann-Whitney and Kruskal Wallis tests were performed using SPSS v22.
Results: A total of 183 patients were reviewed (61 patients per cycle). There was no significant difference between the baseline patient, tumour and treatment factors between all 3 groups. There were no significant differences in seroma incidence (5-day vs 1-day 46% vs 58%, p=NS; 3-day vs 1-day 52% vs 58%, p=NS, number of aspiration (mean 5-day vs 1-day 3 vs 2 p=NS; 3-day vs 1-day 2 vs 2 p=NS) or volume of aspiration (5-day vs 1-day: 716 vs 467mls p=NS; 3-day vs 1-day: 588 vs 467mls p=NS). Factors influencing seroma rates are detailed in Table 1.
Conclusion: Removal of drains after one day does not significantly affect seroma incidence, nor number and volume of seroma aspiration. Seroma rates are affected by poor prognostic factors and extent of axillary disease.
Method: A prospective audit of all patients undergoing breast cancer surgery with mastectomy and/or axillary clearance was performed over 3 time periods when the local drain removal policy changed from <50ml daily or maximum 5 days (Cycle 1) to <50ml daily or maximum 3-day (Cycle 2) to <50ml daily or maximum 1-day (Cycle 3). Mann-Whitney and Kruskal Wallis tests were performed using SPSS v22.
Results: A total of 183 patients were reviewed (61 patients per cycle). There was no significant difference between the baseline patient, tumour and treatment factors between all 3 groups. There were no significant differences in seroma incidence (5-day vs 1-day 46% vs 58%, p=NS; 3-day vs 1-day 52% vs 58%, p=NS, number of aspiration (mean 5-day vs 1-day 3 vs 2 p=NS; 3-day vs 1-day 2 vs 2 p=NS) or volume of aspiration (5-day vs 1-day: 716 vs 467mls p=NS; 3-day vs 1-day: 588 vs 467mls p=NS). Factors influencing seroma rates are detailed in Table 1.
Conclusion: Removal of drains after one day does not significantly affect seroma incidence, nor number and volume of seroma aspiration. Seroma rates are affected by poor prognostic factors and extent of axillary disease.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}